Clinical trials sponsored by Zhejiang Provincial People's Hospital

Phase breakdown

Conditions studied

Recruiting trials led by Zhejiang Provincial People's Hospital

• An Exploratory Study on Gene Methylation Detection of Colorectal Cancer
  NCT07033156 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• An Exploratory Study to Confirm Efficacy of Modified Deep Cervical Lymphovenous Anastomosis (LVA) in Alzheimer's Disease/ Parkinson's Disease
  NCT06852352 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 2 locations
• Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study)
  NCT06530732 · Phase: Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study
  NCT06888050 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis
  NCT07491016 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis
  NCT06979271 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
  NCT07312422 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
  NCT06534762 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
  NCT06722911 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Zhejiang Provincial People's Hospital recruiting for?

Zhejiang Provincial People's Hospital is the lead sponsor of 9 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.